This page shows the latest Natpar news and features for those working in and with pharma, biotech and healthcare.
Becomes first licenced treatment for hypoparathyroidism in Europe. Shire is celebrating an EU approval for its hypoparathyroidism treatment Natpar, two years after getting a green light for the drug in the ... US. Natpar - which is sold as Natpara in the
If approved, the drug will be sold in the EU as Natpar.
The drug could benefit from Shire's marketing muscle on both sides of the Atlantic, said Ornskov, and could soon be joined by Natpara/Natpar (recombinant parathyroid hormone) for the treatment
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...